Axonics, Inc. (AXNX) Financials

AXNX Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 719.9 million 82.4 million
2023-09-30 660.7 million 50.1 million
2023-06-30 649.0 million 33.3 million
2023-03-31 665.7 million 89.1 million

AXNX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 4.3 million 11.1 million
2023-09-30 11.2 million 11.5 million
2023-06-30 -19.5 million 11.2 million
2023-03-31 -1.6 million 10.7 million

AXNX Net Income

No data available :(

AXNX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 345.0 million - 27.6 million
2023-09-30 344.7 million - 2.8 million
2023-06-30 331.5 million - 3.0 million
2023-03-31 357.1 million - 8.7 million

AXNX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 49.4 million
2023-09-30 50.1 million
2023-06-30 49.1 million
2023-03-31 48.6 million

AXNX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.3 million 9.7 million 11.1 million 55.1 million
2023-09-30 1.2 million 8.2 million 11.8 million 47.5 million
2023-06-30 256000 8.9 million 10.7 million 44.3 million
2023-03-31 794000 8.1 million 12.2 million 42.7 million

AXNX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 109.7 million 29.2 million
2023-09-30 93.1 million 24.0 million
2023-06-30 22.7 million 22.7 million
2023-03-31 70.7 million 18.2 million

AXNX

Price: $66.69

52 week price:
47.59
69.68

Earnings Per Share: -0.12 USD

P/E Ratio: -295.22

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Volume: 679900

Market Capitalization: 3.4 billion

Links: